Higher fibre intake tracks with 22% lower cancer risk

Dietary fibre is already recognised as an essential component of a healthy diet, but its relationship with cancer specifically has been studied piecemeal, cancer type by cancer type. Dozens of meta-analyses now exist, each covering a slice of the question and each carrying its own biases. That leaves a reader — and a public health body — unsure how large and how consistent the overall signal really is. This paper set out to synthesise those meta-analyses in one place and to examine the biases running through the evidence base.

The authors ran an umbrella review with meta-meta-analysis, a design that pools existing meta-analyses rather than individual studies. A structured literature search was carried out across PubMed/Medline, Web of Science and Scopus to identify meta-analyses focused on dietary fibre consumption and either cancer risk or cancer mortality. The search yielded 25 papers and 28 reports for synthesis. Primary analyses compared high against low fibre consumption for overall cancer incidence and mortality, with secondary analyses breaking results down by cancer group, including digestive tract cancers and breast cancer.

Higher dietary fibre consumption was associated with a 22% lower cancer risk, with a pooled odds ratio of 0.78 and a 95% confidence interval of 0.74 to 0.83. Cancer mortality was 17% lower in the higher-intake groups, with a risk ratio of 0.83 and a confidence interval of 0.78 to 0.90. In the secondary analysis, the inverse association was strongest for digestive tract cancers, at an odds ratio of 0.68 with a confidence interval of 0.62 to 0.76. Breast cancer showed a smaller but still inverse association, with an odds ratio of 0.92 and a narrow interval of 0.90 to 0.94.

This consolidates a large and reasonably consistent body of observational work into a single estimate, and the direction of effect matches long-standing dietary guidance on fibre. The pattern by cancer site is also biologically coherent, with the clearest association where fibre passes through. What the design cannot do is separate fibre from everything that travels with it: people eating more fibre tend to eat more plants, more whole grains and less processed food, and often differ in smoking, weight and activity. Randomised evidence on hard cancer endpoints is not part of this synthesis, so the causal question stays open.

This is a reason to treat fibre intake as one of the better-evidenced dietary markers of long-term health, while remembering that the underlying studies observe people rather than assign them. The associations reported cover both getting cancer and dying of it, and they are strongest for cancers of the digestive tract. Nobody can tell you from this analysis how much of that benefit comes from fibre itself versus the overall dietary pattern it signals. Taken with everything else known about fibre, it strengthens the general case for fibre-rich eating without turning it into a cancer treatment.